Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior Gliadel implantation (Carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 749-755

  Noël, Georges ^a   Schott, Roland ^a   Froelich, Sébastien ^b   Gaub, Marie Pierre ^b   Boyer, Patrick ^b   Fischer Lokou, David ^b   Dufour, Patrick ^a   Kehrli, Pierre ^b   Maitrot, Daniel ^b  

^a CENTRE PAUL STRAUSS   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Carmustine; High grade glioma; Radiotherapy; Surgery; Temozolomide; Wafers

Indexed keywords

ADJUVANT CHEMOTHERAPY; CARMUSTINE; CHEMORADIOTHERAPY; GLIOBLASTOMAS; GROSS TUMOR VOLUME; HIGH-GRADE GLIOMAS; IRRADIATION DOSE; METHYLTRANSFERASES; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSTIC FACTORS; TEMOZOLOMIDE; WAFERS;

CHEMOTHERAPY; DISEASES; IRRADIATION; MULTIVARIANT ANALYSIS; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY; SURGERY;

TUMORS;

CARMUSTINE; CISPLATIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; CARMUSTINE; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DISEASE-FREE SURVIVAL; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84855836093     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.073     Document Type: Article

References (34)

1. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
2. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
3. S. Valtonen, U. Timonen, and P. Toivanen Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study Neurosurgery 41 1997 44 48 discussion 48-49
4. M. Westphal, D.C. Hilt, and E. Bortey A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 2003 79 88
5. M. Westphal, Z. Ram, and V. Riddle Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial Acta Neurochir (Wien) 148 2006 269 275 discussion 275
6. H. Brem, S. Piantadosi, and P.C. Burger Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1995 1008 1012
7. R.J. Tamargo, J.S. Myseros, and J.I. Epstein Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain Cancer Res 53 1993 329 333
8. A.J. Domb, M. Rock, and J. Schwartz Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain Biomaterials 15 1994 681 688
9. L.K. Fung, M. Shin, and B. Tyler Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain Pharm Res 13 1996 671 682
10. M. Esteller, G. Gaidano, and S.N. Goodman Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma J Natl Cancer Inst 94 2002 26 32
11. M. Esteller, S.R. Hamilton, and P.C. Burger Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Res 59 1999 793 797
12. M. Esteller, M. Toyota, and M. Sanchez-Cespedes Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis Cancer Res 60 2000 2368 2371
13. W. Roa, P.M. Brasher, and G. Bauman Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
14. D.R. Macdonald, T.L. Cascino, and S.C. Schold Jr. Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280
15. B.M. Spiegel, E. Esrailian, and L. Laine Clinical impact of adjuvant chemotherapy in glioblastoma multiforme: A meta-analysis CNS Drugs 21 2007 775 787
16. H.S. Friedman, M.E. Dolan, and R.C. Moschel Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme J Natl Cancer Inst 84 1992 1926 1931
17. L. Liu, S. Markowitz, and S.L. Gerson Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea Cancer Res 56 1996 5375 5379
18. S.R. Wedge, J.K. Porteous, and E.S. Newlands 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity Br J Cancer 74 1996 1030 1036
19. J. Plowman, W.R. Waud, and A.D. Koutsoukos Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea Cancer Res 54 1994 3793 3799
20. E. Pan, S.B. Mitchell, and J.S. Tsai A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients J Neurooncol 88 2008 353 357
21. M.J. McGirt, K.D. Than, and J.D. Weingart Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme J Neurosurg 2008
22. F.K. Albert, M. Forsting, and K. Sartor Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis Neurosurgery 34 1994 45 60 discussion 60-41
23. M. Glantz, M. Chamberlain, and Q. Liu Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas Cancer 97 2003 2262 2266
24. Laigle-Donadey F, Figarella-Branger D, Chinot O, et al. Up-front temozolomide in elderly patients with glioblastoma. J Neurooncol.
25. C.R. Heery, A. Desjardins, and J.A. Quinn Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma J Clin Oncol 24 2006 11504 (abstract)
26. R.V. La Rocca, J. Hodes, and W.G. Villanueva A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion Neuro-oncol 8 2006 391 500 (abstract)
27. S.L. Gerson MGMT: Its role in cancer aetiology and cancer therapeutics Nat Rev Cancer 4 2004 296 307
28. B. Kaina, M. Christmann, and S. Naumann MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents DNA Repair (Amst) 6 2007 1079 1099
29. M. Weller, R. Stupp, and G. Reifenberger MGMT promoter methylation in malignant gliomas: Ready for personalized medicine? Nat Rev Neurol 6 2010 39 51
30. M.E. Hegi, A.C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
31. W. Wick, C. Hartmann, and C. Engel NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide J Clin Oncol 27 2009 5874 5880
32. M.J. van den Bent, H.J. Dubbink, and M. Sanson MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: A report from EORTC Brain Tumor Group Study 26951 J Clin Oncol 27 2009 5881 5886
33. S. Gururangan, L. Cokgor, and J.N. Rich Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas Neuro Oncol 3 2001 246 250
34. T. Ryken, T. Carlisle, and J. Buatti Treatment of adults with newly diagnosed glioblastoma with surgery, Gliadel wafers and limited field radiation plus concomitant temozolomide followed by adjuvant temozolomide J Clin Oncol 26 2008 13003 (abstract)